Perspective Therapeutics Inc (CATX)
1.58
-0.02
(-1.25%)
USD |
NYAM |
Apr 26, 16:00
1.59
+0.01
(+0.63%)
After-Hours: 20:00
Perspective Therapeutics Enterprise Value: 919.81M for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 919.81M |
| April 25, 2024 | 931.55M |
| April 24, 2024 | 984.38M |
| April 23, 2024 | 990.24M |
| April 22, 2024 | 890.47M |
| April 19, 2024 | 872.86M |
| April 18, 2024 | 855.25M |
| April 17, 2024 | 831.78M |
| April 16, 2024 | 849.38M |
| April 15, 2024 | 890.47M |
| April 12, 2024 | 855.25M |
| April 11, 2024 | 825.91M |
| April 10, 2024 | 884.60M |
| April 09, 2024 | 902.21M |
| April 08, 2024 | 866.99M |
| April 05, 2024 | 861.12M |
| April 04, 2024 | 825.91M |
| April 03, 2024 | 837.65M |
| April 02, 2024 | 849.38M |
| April 01, 2024 | 743.74M |
| March 28, 2024 | 690.92M |
| March 27, 2024 | 696.79M |
| March 26, 2024 | 720.26M |
| March 25, 2024 | 732.00M |
| March 22, 2024 | 737.87M |
| Date | Value |
|---|---|
| March 21, 2024 | 778.80M |
| March 20, 2024 | 696.65M |
| March 19, 2024 | 649.70M |
| March 18, 2024 | 558.75M |
| March 15, 2024 | 620.36M |
| March 14, 2024 | 620.36M |
| March 13, 2024 | 649.70M |
| March 12, 2024 | 667.31M |
| March 11, 2024 | 661.44M |
| March 08, 2024 | 690.78M |
| March 07, 2024 | 614.50M |
| March 06, 2024 | 591.02M |
| March 05, 2024 | 497.17M |
| March 04, 2024 | 516.97M |
| March 01, 2024 | 461.94M |
| February 29, 2024 | 437.67M |
| February 28, 2024 | 437.62M |
| February 27, 2024 | 437.62M |
| February 26, 2024 | 437.62M |
| February 23, 2024 | 467.30M |
| February 22, 2024 | 462.35M |
| February 21, 2024 | 451.77M |
| February 20, 2024 | 445.09M |
| February 16, 2024 | 426.59M |
| February 15, 2024 | 423.28M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-24.64M
Minimum
Sep 29 2022
990.24M
Maximum
Apr 23 2024
74.31M
Average
36.97M
Median
Enterprise Value Benchmarks
| Retractable Technologies Inc | -13.34M |
| InfuSystems Holdings Inc | 201.54M |
| Xtant Medical Holdings Inc | 139.78M |
| Asensus Surgical Inc | 46.66M |
| Catheter Precision Inc | 0.7635M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -24.68M |
| Revenue (Quarterly) | -5.239M |
| Total Expenses (Quarterly) | 2.589M |
| EPS Diluted (Quarterly) | -0.09 |
| Earnings Yield | -10.86% |
| Normalized Earnings Yield | -8.963 |